| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A16AX15 |
| UNII: | 381V4FCV2Z |
| InChI Key | NCLGDOBQAWBXRA-PGRDOPGGSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H22ClF3N6O3 |
| Molecular Weight | 546.94 |
| AlogP | 4.51 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 142.17 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 38.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tryptophan 5-hydroxylase inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 16-16 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Malignant Carcinoid Syndrome | 3 | D008303 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2103855 |
| DrugBank | DB14218 |
| EPA CompTox | DTXSID60145805 |
| FDA SRS | 381V4FCV2Z |
| PubChem | 25025298 |
| SureChEMBL | SCHEMBL612353 |
| ZINC | ZINC000084758235 |